Abstract
Versican, a large chondroitin sulfate proteoglycan, plays a role in conditions such as wound healing and tissue remodelling. To test the hypothesis that versican expression is transiently upregulated and plays a role in the infarcted heart, we examined its expression in a rat model of myocardial infarction. Northern blot analysis demonstrated increased expression of versican mRNA. Quantitative real-time RT-PCR analysis revealed that versican mRNA began to increase as early as 6 h and reached its maximal level 2 days after coronary artery ligation. Versican mRNA then gradually decreased, while the mRNA of decorin, another small proteoglycan, increased thereafter. Versican mRNA was localized in monocytes, as indicated by CD68-positive staining, around the infarct tissue. The induction of versican mRNA was accelerated by ischemia/reperfusion (I/R), which was characterized by massive cell infiltration and enhanced inflammatory response. To examine the alteration of versican expression in monocytes/macrophages, we isolated human peripheral blood mononuclear cells and stimulated them with granulocyte/macrophage colony-stimulating factor (GM-CSF). Stimulation of mononuclear cells with GM-CSF increased the expression of versican mRNA as well as cytokine induction. The production of versican by monocytes in the infarct area represents a novel finding of the expression of an extracellular matrix gene by monocytes in the infarcted heart. We suggest that upregulation of versican in the infarcted myocardium may have a role in the inflammatory reaction, which mediates subsequent chemotaxis in the infarcted heart. (Mol Cell Biochem xxx: 47–56, 2005)
Similar content being viewed by others
References
Guan JL, Chen HC: Signal transduction in cell–matrix interactions. Int Rev Cytol 168: 81–121, 1996
Yamasaki S, Kusachi S, Moritani H, Kondo J, Hirohata S, Tamura A, Tsuji T: Reperfusion hastens appearance and extent of distribution of type I collagen in infarct zone: immunohistochemical study in rat experimental infarction. Cardiovasc Res 30: 763–768, 1995
Russell DL, Ochsner SA, Hsieh M, Mulders S, Richards JS: Hormone-regulated expression and localization of versican in the rodent ovary. Endocrinology 144: 1020–1031, 2003
Naso MF, Morgan JL, Buchberg AM, Siracusa LD, Iozzo RV: Expression pattern and mapping of the murine versican gene (Cspg2) to chromosome 13. Genomics 29: 297–300, 1995
Henderson DJ, Copp AJ: Versican expression is associated with chamber specification, septation, and valvulogenesis in the developing mouse heart. Circ Res 83: 523–532, 1998
Zheng PS, Wen J, Ang LC, Sheng W, Viloria-Petit A, Wang Y, Wu Y, Kerbel RS, Yang BB: Versican/PG-M G3 domain promotes tumor growth and angiogenesis. Faseb J 18: 754–756, 2004
Toole BP, Wight TN, Tammi MI: Hyaluronan-cell interactions in cancer and vascular disease. J Biol Chem 277: 4593–4596, 2002
de la Motte CA, Hascall VC, Drazba J, Bandyopadhyay SK, Strong SA: Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid:polycytidylic acid:inter-alpha-trypsin inhibitor is crucial to structure and function. Am J Pathol 163: 121–133, 2003
Ross R: Atherosclerosis – an inflammatory disease. N Engl J Med 340: 115–126, 1999
Gasson JC: Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood 77: 1131–1145, 1991
Maekawa Y, Anzai T, Yoshikawa T, Sugano Y, Mahara K, Kohno T, Takahashi T, Ogawa S: Effect of granulocyte-macrophage colony-stimulating factor inducer on left ventricular remodeling after acute myocardial infarction. J Am Coll Cardiol 44: 1510–1520, 2004
Iwabu A, Murakami T, Kusachi S, Nakamura K, Takemoto S, Komatsubara I, Sezaki S, Hayashi J, Ninomiya Y, Tsuji T: Concomitant expression of heparin-binding epidermal growth factor-like growth factor mRNA and basic fibroblast growth factor mRNA in myocardial infarction in rats. Basic Res Cardiol 97: 214–222, 2002
Takeda K, Kusachi S, Ohnishi H, Nakahama M, Murakami M, Komatsubara I, Oka T, Doi M, Ninomiya Y, Tsuji T: Greater than normal expression of the collagen-binding stress protein heat-shock protein-47 in the infarct zone in rats after experimentally-induced myocardial infarction. Coron Artery Dis 11: 57–68, 2000
Murakami M, Kusachi S, Nakahama M, Naito I, Murakami T, Doi M, Kondo J, Higashi T, Ninomiya Y, Tsuji T: Expression of the alpha 1 and alpha 2 chains of type IV collagen in the infarct zone of rat myocardial infarction. J Mol Cell Cardiol 30: 1191–1202, 1998
Inoue K, Kusachi S, Niiya K, Kajikawa Y, Tsuji T: Sequential changes in the distribution of type I and III collagens in the infarct zone: immunohistochemical study of experimental myocardial infarction in the rat. Coron Artery Dis 6: 153–158, 1995
Komatsubara I, Murakami T, Kusachi S, Nakamura K, Hirohata S, Hayashi J, Takemoto S, Suezawa C, Ninomiya Y, Shiratori Y: Spatially and temporally different expression of osteonectin and osteopontin in the infarct zone of experimentally induced myocardial infarction in rats. Cardiovasc Pathol 12: 186–194, 2003
Nakamura K, Hirohata S, Murakami T, Miyoshi T, Demircan K, Oohashi T, Ogawa H, Koten K, Toeda K, Kusachi S, Ninomiya Y, Shiratori Y: Dynamic induction of ADAMTS1 gene in the early phase of acute myocardial infarction. J Biochem (Tokyo) 136: 439–446, 2004
Nakamura Y, Yoshiyama M, Omura T, Yoshida K, Izumi Y, Takeuchi K, Kim S, Iwao H, Yoshikawa J: Beneficial effects of combination of ACE inhibitor and angiotensin II type 1 receptor blocker on cardiac remodeling in rat myocardial infarction. Cardiovasc Res 57: 48–54, 2003
Moritani H, Kusachi S, Takeda K, Doi M, Ohnishi H, Komatsubara I, Nakahama M, Higashi T, Ninomiya Y, Tsuji T: Reperfusion accelerates the distribution of type I and III collagen messenger RNA expression after acute myocardial infarction: In situ hybridization in experimental infarction in rats. Coron Artery Dis 10: 89–96, 1999
Cattaruzza S, Schiappacassi M, Ljungberg-Rose A, Spessotto P, Perissinotto D, Morgelin M, Mucignat MT, Colombatti A, Perris R: Distribution of PG-M/versican variants in human tissues and de novo expression of isoform V3 upon endothelial cell activation, migration, and neoangiogenesis in vitro. J Biol Chem 277: 47626–47635, 2002
Hirohata S, Kusachi S, Kondo J, Sano I, Murakami M, Doi M, Ninomiya Y, Tsuji T: Laminin alpha 1, alpha 2, alpha 4 and beta 1 chain mRNA expression in mouse embryonic, neonatal, and adult hearts. Jpn Heart J 38: 281–289, 1997
Takemoto S, Murakami T, Kusachi S, Iwabu A, Hirohata S, Nakamura K, Sezaki S, Havashi J, Suezawa C, Ninomiya Y, Tsuji T: Increased expression of dermatopontin mRNA in the infarct zone of experimentally induced myocardial infarction in rats: comparison with decorin and type I collagen mRNAs. Basic Res Cardiol 97: 461–468, 2002
Ogawa H, Oohashi T, Sata M, Bekku Y, Hirohata S, Nakamura K, Yonezawa T, Kusachi S, Shiratori Y, Ninomiya Y. Lp3/Hapln3, a novel link protein that co-localizes with versican and is coordinately up-regulated by platelet-derived growth factor in arterial smooth muscle cells. Matrix Biol 23: 287–298, 2004
Demircan K, Hirohata S, Nishida K, Hatipoglu OF, Oohashi T, Yonezawa T, Apte SS, and Ninomiya Y: ADAMTS-9 is synergistically induced by interleukin-1beta and tumor necrosis factor alpha in OUMS-27 chondrosarcoma cells and in human chondrocytes. Arthritis Rheum 52: 1451–1460, 2005
Hurskainen TL, Hirohata S, Seldin MF, Apte SS: ADAM-TS5, ADAM-TS6, and ADAM-TS7, novel members of a new family of zinc metalloproteases. General features and genomic distribution of the ADAM-TS family. J Biol Chem 274: 25555–25563, 1999
Doi M, Kusachi S, Murakami T, Ninomiya Y, Murakami M, Nakahama M, Takeda K, Komatsubara I, Naito I, Tsuji T: Time-dependent changes of decorin in the infarct zone after experimentally induced myocardial infarction in rats: comparison with biglycan. Pathol Res Pract 196: 23–33, 2000
Naldini A, Pucci A, Carney DH, Fanetti G, Carraro F: Thrombin enhancement of interleukin-1 expression in mononuclear cells: involvement of proteinase-activated receptor-1. Cytokine 20: 191–199, 2002
Fishbein MC, Maclean D, Maroko PR: Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution. Am J Pathol 90: 57–70, 1978
Gwechenberger M, Mendoza LH, Youker KA, Frangogiannis NG, Smith CW, Michael LH, Entman ML: Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions. Circulation 99: 546–551, 1999
Kukielka GL, Smith CW, Manning AM, Youker KA, Michael LH, Entman ML: Induction of interleukin-6 synthesis in the myocardium. Potential role in postreperfusion inflammatory injury. Circulation 92: 1866–1875, 1995
Formato M, Farina M, Spirito R, Maggioni M, Guarino A, Cherchi G M, Biglioli P, Edelstein C, Scanu AM: Evidence for a proinflammatory and proteolytic environment in plaques from endarterectomy segments of human carotid arteries. Arterioscler Thromb Vasc Biol 24: 129–135, 2004
Yamamoto K, Kusachi S, Ninomiya Y, Murakami M, Doi M, Takeda K, Shinji T, Higashi T, Koide N, Tsuji T: Increase in the expression of biglycan mRNA expression Co-localized closely with that of type I collagen mRNA in the infarct zone after experimentally-induced myocardial infarction in rats. J Mol Cell Cardiol 30: 1749–1756, 1998
Ahmed MS, Oie E, Vinge LE, Yndestad A, Andersen GG, Andersson Y, Attramadal T, Attramadal H: Induction of myocardial biglycan in heart failure in rats – an extracellular matrix component targeted by AT(1) receptor antagonism. Cardiovasc Res 60: 557–568, 2003
Endo C, Kusachi S, Ninomiya Y, Yamamoto K, Murakami M, Murakami T, Shinji T, Koide N, Kondo J, Tsuji T: Time-dependent increases in syndecan-1 and fibroglycan messenger RNA expression in the infarct zone after experimentally induced myocardial infarction in rats. Coron Artery Dis 8: 155–161, 1997
Wight TN, Merrilees MJ: Proteoglycans in atherosclerosis and restenosis: Key roles for versican. Circ Res 94: 1158–1167, 2004
Makatsori E, Lamari FN, Theocharis AD, Anagnostides S, Hjerpe A, Tsegenidis T, Karamanos NK: Large matrix proteoglycans, versican and perlecan, are expressed and secreted by human leukemic monocytes. Anticancer Res 23: 3303–3309, 2003
Chomarat P, Banchereau J, Davoust J, Palucka AK: IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat Immunol 1: 510–514, 2000
Frangogiannis NG, Mendoza LH, Ren G, Akrivakis S, Jackson PL, Michael LH, Smith CW, Entman ML: MCSF expression is induced in healing myocardial infarcts and may regulate monocyte and endothelial cell phenotype. Am J Physiol Heart Circ Physiol 285: H483–492, 2003
Frangogiannis NG, Smith CW, Entman ML: The inflammatory response in myocardial infarction. Cardiovasc Res 53: 31–47, 2002
Parissis JT, Adamopoulos S, Venetsanou K, Kostakis G, Rigas A, Karas SM, Kremastinos D: Plasma profiles of circulating granulocyte-macrophage colony-stimulating factor and soluble cellular adhesion molecules in acute myocardial infarction. Contribution to post-infarction left ventricular dysfunction. Eur Cytokine Netw 15: 139–144, 2004
Woldbaek PR, Hoen IB, Christensen G, Tonnessen T: Gene expression of colony-stimulating factors and stem cell factor after myocardial infarction in the mouse. Acta Physiol Scand 175: 173–181, 2002
Buschmann IR, Hoefer IE, van Royen N, Katzer E, Braun-Dulleaus R, Heil M, Kostin S, Bode C, Schaper W: GM-CSF: a strong arteriogenic factor acting by amplification of monocyte function. Atherosclerosis 159: 343–356, 2001
Shyy YJ, Li YS, Kolattukudy PE: Activation of MCP-1 gene expression is mediated through multiple signaling pathways. Biochem Biophys Res Commun 192: 693–699, 1993
Rollins BJ, Yoshimura T, Leonard EJ, Pober JS: Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. Am J Pathol 136: 1229–1233, 1990
Bozinovski S, Jones JE, Vlahos R, Hamilton JA, Anderson GP: Granulocyte/macrophage-colony-stimulating factor (GM-CSF) regulates lung innate immunity to lipopolysaccharide through Akt/Erk activation of NFkappa B and AP-1 in vivo. J Biol Chem 277: 42808–42814, 2002
Shimizu-Hirota R, Sasamura H, Mifune M, Nakaya H, Kuroda M, Hayashi M, Saruta T: Regulation of vascular proteoglycan synthesis by angiotensin II type 1 and type 2 receptors. J Am Soc Nephrol 12: 2609–2615, 2001
Lemire JM, Merrilees MJ, Braun KR, Wight TN: Overexpression of the V3 variant of versican alters arterial smooth muscle cell adhesion, migration, and proliferation in vitro. J Cell Physiol 190: 38–45, 2002
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Toeda, K., Nakamura, K., Hirohata, S. et al. Versican is induced in infiltrating monocytes in myocardial infarction. Mol Cell Biochem 280, 47–56 (2005). https://doi.org/10.1007/s11010-005-8051-4
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11010-005-8051-4